Lose weight, alleviate stress, sleep more or improve memory. This softgel supplement, once only available as an expensive product made from bovine sources, Phosphatidyl serine is now produced in a soybean extract. A nutrient that works in the cell membranes of the brain to carry signals, Phosphatidyl serine helps control stress hormones. It also assists in maintaining adequate glucose utilization in the brain, which may slow declining brain activity and enhance memory in the elderly. You can also use it as a dietary supplement.
- Technical Specs
Phosphatidyl serine softgels may be a useful dietary supplement for individuals who wish to support the body’s nervous system and brain function.
Ingredients / Formula
Each softgel contains:
Total Phospholipids 500 mg
- Phosphatidylserine 100 mg
- Phosphatidylcholine 45 mg
- Phosphatidylethanolamine 10 mg
- Phosphatidylinositol 5 mg
- Fatty Acids (free and phospholipid-bound) 360 mg
One to three capsules daily or before bed as directed by health care provider. Phosphatidyl serine should be taken with meals.
No adverse effects have been reported.
Store in a cool, dry place, away from direct light. Keep out of reach of children.
- Extended Information
These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure, or prevent any disease.
Allegro L, Favaretto V, Ziliotto G. Oral phosphatidyl serine in elderly patients with cognitive deterioration. Clin Trials J 1987;24:104-108.
Amaducci L, Crook TH, Lippi A, et al. Use of phosphatidyl serine in Alzheimer's disease. Ann N Y Acad Sci 1991;640:245-249.
Amaducci L, the SMID Group. Phosphatidyl serine in the treatment of Alzheimer's disease: Results of a multicenter study. Psychopharmacol Bull 1988;24:130-134.
Caffarra P, Santamaria V. The effects of phosphatidyl serine in patients with mild cognitive decline. Clin Trials J 1987;24:109-114.
Cenacchi T, Bertoldin T, Farina C, Fiori MG, Crepaldi G. Cognitive decline in the elderly: A double-blind, placebo-controlled multicenter study on efficacy of phosphatidyl serine administration. Aging Clin Exp Res 1993;5:123-133. Psychopharmacol Bull 1992;28:61-66.
Crook TH, Tinklenberg J, Yesavage J, Petrie W, Nunzi MG, Massari DC. Effects of phosphatidyl serine in age-associated memory impairment. Neurology 1991;41:644-649.
Delwaide PJ, Gyselynck-Mambourg AM, Hurlet A, Ylieff M. Double-blind randomized controlled study of phosphatidyl serine in senile 86; 73:136-140.
Funfgeld EW, Nedwidek P. Neurohomologous phosphatidyl serine in Parkinsonian patients with associated disorders of cerebral metabolism: Results of a pilot study. Clin Trials J 1987;24:42-61.
Granata O, DiMichele J. Phosphatidyl serine in elderly patients: An open trial. Clin Trials J 1987;24:99-103.
Heiss WD, Kessler J, Mielke R, Szelies B, Herholz K. Long-term effects of phosphatidyl serine, pyritinol, and cognitive training in Alzheimer's disease. A neuropsychological, EEG, and PET investigation. Dementia 1994;5:88-98.
Heiss WD, Kessler J, Slansky I, Mielke R, Szelies B, Herholz K.Activation PET as an instrument to determine therapeutic efficacy in Alzheimer's disease. Ann N Y Acad Sci 1993;695:327-331.
Heiss WD, Szelies B, Kessler J, Herholz K. Abnormalities of energy metabolism in Alzheimer's disease studied with PET. Ann N Y Acad Sci 1991;640:65-71.
Heywood R, Cozens DD, Richold M. Toxicology of a phosphatidyl serine preparation from bovine brain (BC-PS). Clin Trials J 1987;24:25-32.
aggioni M, Picotti GB, Bondiolotti GP, et al. Effects of phosphatidyl serine therapy in geriatric patients with depressive disorders. Acta Psychiatr Scand 1990;81:265-270.
Monteleone P, Maj M, Beinat L, Natale M, Kemali D. Blunting by chronic phosphatidyl serine administration of the stress-induced activation of the hypothalamo-pituitary-adrenal axis in healthy men. Eur J Clin Pharmacol 1992;41:385-388.
Monteleone P, Beinat L, Tanzillo C, Maj M, Kemali D. Effects of phosphatidyl serine on the neuroendocrine response to physical stress in humans. Neuroendocrinology 1990;52:243-248.
Palmieri G, Palmieri R, Inzoli MR, et al. Double-blind controlled trial of phosphatidyl serine in patients with senile mental deterioration. Clin Trials J 1987;24:73-83.
Pepeu G, Casamenti F, Pepeu IM, Scali C. The brain cholinergic system in ageing mammals. J Reprod Fertil Suppl 1993;46:155-162.
Puca FM, Savarese MA, Minervini MG. Exploratory trial of phosphatidyl serine efficacy in mildly demented elderly patients. Clin Trials J 1987;24:94-98.
Ransmayr G, Plorer S, Gerstenbrand F, Bauer G. Double-blind placebocontrolledtrial of phosphatidyl serine in elderly patients with arteriosclerotic encephalopathy. Clin Trials J 1987;24:62-72.
Rosadini G, Sannita WG, Nobili F, Cenacchi T. Phosphatidyl serine: quantitative EEG effects in healthy volunteers. Neuropsychobiology 1990;24:42-48.